Clearmind Medicine Inc. Common Shares Strategic Asset Allocation Index
Clearmind Medicine Inc. Common Shares strategic asset allocation index. Clearmind Medicine Inc. Common Shares (CMND) has a Strategic Asset Allocation Index of 0.3% as of July 2023. Strategic assets (PP&E of $7.30K plus long-term investments of $-) total $7.30K, measured against net assets of $2.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Clearmind Medicine Inc. Common Shares (CMND) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Clearmind Medicine Inc. Common Shares (2018–2021)
Strategic asset allocation index of Clearmind Medicine Inc. Common Shares from 2018 to 2021. This chart shows how Clearmind Medicine Inc. Common Shares's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of July 2023, the index stands at 0.3%, representing strategic assets of $7.30K against net assets of $2.13 Million USD.
Clearmind Medicine Inc. Common Shares Strategic Asset Allocation Index by Year (2018–2021)
Clearmind Medicine Inc. Common Shares strategic asset allocation index by year from 2018 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CMND stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.5% | $20.58K | $20.58K | $- | $3.87 Million | ▼ -171.3 pp |
| 2019 | 171.8% | $174.59K | $174.59K | $- | $101.63K | ▲ +81.5 pp |
| 2018 | 90.3% | $164.59K | $164.59K | $- | $182.24K | — |